Ligny G, Smets P
Biomedicine. 1978 Jan-Feb;28(1):35-41.
Fourteen hypochlorhydric patients suffering from atrophic gastritis were tested with pentagastrin and randomly distributed in groups treated per os : one by a placebo, the other by eserine amine oxide. In the placebo group we did not observe a variation in the acid output nor in the acid concentration of the parietal component. In the patients treated with eserine amine oxide, the acid secretion and the acid concentration of the parietal component increased on treatment (p less than 0.01). In two other groups of hypochlorhydric patients tested with pentagastrin (n = 25) or with histamine ( n = 38) and treated for periods of one to three months we also observed an increase in the acid output and the acid concentration of the parietal component. These facts could be explained by an increase in the number of functional cell units, accompanied by a qualitative variation in the parietal component during treatment the patients suffering from atrophic gastritis.
对14例患有萎缩性胃炎的胃酸过少患者用五肽胃泌素进行检测,并随机分为口服治疗组:一组服用安慰剂,另一组服用氧化毒扁豆碱胺。在安慰剂组,我们未观察到胃酸分泌量及壁细胞成分酸浓度的变化。在用氧化毒扁豆碱胺治疗的患者中,治疗期间壁细胞成分的酸分泌及酸浓度增加(P<0.01)。在另外两组分别用五肽胃泌素(n = 25)或组胺(n = 38)检测并治疗1至3个月的胃酸过少患者中,我们也观察到壁细胞成分的胃酸分泌量及酸浓度增加。这些事实可以用功能性细胞单位数量的增加来解释,同时在萎缩性胃炎患者治疗期间壁细胞成分存在质的变化。